Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab

References

• Headache Classification of the International Headache SocietyThe international classification of headache disorders, 3rd edition (beta version)Cephalalgia20133362780823771275
   PubMed Web of Science ®Google Scholar
• GiamberardinoMAMartellettiPEmerging drugs for migraine treatmentExpert Opin Emerg Drugs20152011374725547922
   PubMed Web of Science ®Google Scholar
• AffaitatiGMartellettiPLopopoloMUse of nonsteroidal antiinflammatory drugs for symptomatic treatment of episodic headachePain Pract201717339240127207273
   PubMed Web of Science ®Google Scholar
• BartoliniMGiamberardinoMALisottoCA double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraineJ Headache Pain201112336136821437714
   PubMed Web of Science ®Google Scholar
• BelleiEMonariEBergaminiSValidation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headacheJ Headache Pain20151655926272683
   PubMed Web of Science ®Google Scholar
• NegroACurtoMLionettoLGiamberardinoMAMartellettiPChronic migraine treatment: from onabotulinumtoxinA onwardsExpert Rev Neurother201616101217122727310178
   PubMed Web of Science ®Google Scholar
• TanaCTafuriETanaMNew insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?J Headache Pain201319
   Web of Science ®Google Scholar
• LionettoLBorroMCurtoMChoosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerationsExpert Opin Drug Metab Toxicol20161239940626878379
   PubMed Web of Science ®Google Scholar
• GiamberardinoMAAffaitatiGCostantiniRChapter 24. Referred pain from internal organsHandb Clin Neurol20068134336118808846
   PubMedGoogle Scholar
• GiamberardinoMAAffaitatiGCostantiniRVisceral referred painJ Musculoske Pain201018403410
   Web of Science ®Google Scholar
• GiamberardinoMAAffaitatiGFabrizioACostantiniRMyofascial pain syndromes and their evaluationBest Pract Res Clin Rheumatol20112518519822094195
   PubMed Web of Science ®Google Scholar
• GiamberardinoMAAffaitatiGFabrizioACostantiniREffects of treatment of myofascial trigger points on the pain of fibromyalgiaCurr Pain Headache Rep201115539339921541831
   PubMed Web of Science ®Google Scholar
• GiamberardinoMAAffaitatiGMartellettiPImpact of migraine on fibromyalgia symptomsJ Headache Pain2015172827002510
   PubMed Web of Science ®Google Scholar
• GiamberardinoMATanaCCostantiniRPain thresholds in women with chronic pelvic painCurr Opin Obstet Gynecol201426425325924921647
   PubMed Web of Science ®Google Scholar
• BigalMEWalterSRapoportAMTherapeutic antibodies against CGRP or its receptorBr J Clin Pharmacol20157988689525614243
   PubMed Web of Science ®Google Scholar
• IyengarSOssipovMHJohnsonKWThe role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migrainePain2017158454355928301400
   PubMed Web of Science ®Google Scholar
• KarsanNGoadsbyPJCalcitonin gene-related peptide and migraineCurr Opin Neurol20152825025425887765
   PubMed Web of Science ®Google Scholar
• MitsikostasDDRapoportAMNew players in the preventive treatment of migraineMC Med201513279
   Google Scholar
• Wrobel GoldbergSSilbersteinSDTargeting CGRP: a new era for migraine treatmentCNS Drugs20152944345226138383
   PubMed Web of Science ®Google Scholar
• RosenfeldMGMermodJJAmaraSGProduction of a novel neuropeptide encoded by the calcitonin gene via tissue specific RNA processingNature19833041291356346105
   PubMed Web of Science ®Google Scholar
• EftekhariSSalvatoreCAJohanssonSChenTBZengZEdvinssonLLocalization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the bloodbrain barrierBrain Res201516009310925463029
   PubMed Web of Science ®Google Scholar
• EftekhariSWarfvingeKBlixtFWEdvinssonLDifferentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular systemJ Pain2013141289130323958278
   PubMed Web of Science ®Google Scholar
• MulderryPKGhateiMASpokesRADifferential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the ratNeuroscience1988251952052839796
   PubMed Web of Science ®Google Scholar
• SchouWSAshinaSAminFMGoadsbyPJAshinaMCalcitonin gene-related peptide and pain: a systematic reviewJ Headache Pain20171813428303458
   PubMed Web of Science ®Google Scholar
• WimalawansaSJMorrisHREtienneABlenchIPanicoMMacIntyreIIsolation, purification and characterization of beta-hCGRP from human spinal cordBiochem Biophys Res Commun199016799310002322288
   PubMed Web of Science ®Google Scholar
• MarvizónJCPérezOASongBCalcitonin receptor-like receptor and receptor activity modifying protein 1 in the rat dorsal horn: localization in glutamatergic presynaptic terminals containing opioids and adrenergic alpha2C receptorsNeuroscience200714825026517614212
   PubMed Web of Science ®Google Scholar
• OkuRSatohMFujiiNOtakaAYajimaHTakagiHCalcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in ratsBrain Res19874033503542435372
   PubMed Web of Science ®Google Scholar
• RussellFAKingRSmillieS-JKodjiXCalcitonin generelated peptide: physiology and pathophysiologyBrain Physiol Rev2014941099114225287861
   PubMed Web of Science ®Google Scholar
• SeyboldVSThe role of peptides in central sensitizationHandb Exp Pharmacol2009194451491
   Google Scholar
• BrainSDGrantADVascular actions of calcitonin gene-related peptide and adrenomedullinPhysiol Rev20048490393415269340
   PubMed Web of Science ®Google Scholar
• AsgharMSHansenAEAminFMEvidence for a vascular factor in migraineAnn Neurol20116963564521416486
   PubMed Web of Science ®Google Scholar
• HansenJMHaugeAWOlesenJAshinaMCalcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with auraCephalalgia2010301179118620855363
   PubMed Web of Science ®Google Scholar
• LassenLHaderslevPJacobsenVIversenHSperlingBOlesenJCGRP may play a causative role in migraineCephalalgia200225461
   Web of Science ®Google Scholar
• LassenLHJacobsenVBHaderslevPAInvolvement of calcitonin gene related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patientsJ Headache Pain2008915115718437288
   PubMed Web of Science ®Google Scholar
• PetersenKALassenLHBirkSLeskoLOlesenJBIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatationClin Pharmacol Ther20053202213
   Web of Science ®Google Scholar
• DurhamPLCalcitonin gene-related peptide (CGRP) and migraineHeadache2006461S3S816927957
   PubMed Web of Science ®Google Scholar
• EftekhariSSalvatoreCACalamariAKaneSATajtiJEdvinssonLDifferential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglionNeuroscience201016968369620472035
   PubMed Web of Science ®Google Scholar
• MooreELSalvatoreCATargeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraineBr J Pharmacol2012166667821871019
   PubMed Web of Science ®Google Scholar
• GoadsbyPJRecent advances in understanding migraine mechanisms, molecules and therapeuticsTrends Mol Med200713394417141570
   PubMed Web of Science ®Google Scholar
• BernsteinCBursteinRSensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiologyJ Clin Neurol20128899922787491
   PubMed Web of Science ®Google Scholar
• TheoharidesTCDonelanJKandere-GrzybowskaKKonstantinidouAThe role of mast cells in migraine pathophysiologyBrain Res Brain Res Rev2005491657615960987
   PubMedGoogle Scholar
• CapuanoADe CoratoALisiLTringaliGNavarraPDello RussoCProinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathologyMol Pain200954319660121
   PubMed Web of Science ®Google Scholar
• CapuanoADe CoratoALisiLTringaliGNavarraPDello RussoCTrigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1b pro-inflammatory effectsJ Neuroimmunol2011237394621719118
   PubMed Web of Science ®Google Scholar
• Eikermann-HaerterKNegroAAyataCSpreading depression and the clinical correlates of migraineRev Neurosci20132435336323907418
   PubMed Web of Science ®Google Scholar
• LevyDMigraine pain and nociceptor activation – where do we stand?Headache20105090991620546325
   PubMed Web of Science ®Google Scholar
• RecoberAKaiserEAKuburasARussoAFInduction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRPNeuropharmacology20105815616519607849
   PubMed Web of Science ®Google Scholar
• RecoberAKuburasAZhangZWemmieJAAndersonMGRussoAFRole of calcitonin generelated peptide in light-aversive behavior: implications for migraineJ Neurosci2009298798880419587287
   PubMed Web of Science ®Google Scholar
• MulderryPKGhateiMABishopAEAllenYSPolakJMBloomSRDistribution and chromatographic characterisation of CGRP-like immunoreactivity in the brain and gut of the ratRegul Pept1985121331433877953
   PubMedGoogle Scholar
• GoadsbyPJEdvinssonLEkmanRRelease of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular systemAnn Neurol1988231931962454066
   PubMed Web of Science ®Google Scholar
• GoadsbyPJEdvinssonLEkmanRVasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnn Neurol1990281831871699472
   PubMed Web of Science ®Google Scholar
• CadyRKVauseCVHoTWBigalMEDurhamPLElevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptanHeadache2009491258126619788468
   PubMed Web of Science ®Google Scholar
• GoadsbyPJEdvinssonLThe trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and catsAnn Neurol19933348568388188
   PubMed Web of Science ®Google Scholar
• AshinaMBendtsenLJensenRSchifterSOlesenJEvidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacksPain20008613313810779670
   PubMed Web of Science ®Google Scholar
• Cernuda-MorollónELarrosaDRamónCVegaJMartínez-CamblorPPascualJInterictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraineNeurology2013811191119623975872
   PubMed Web of Science ®Google Scholar
• EdvinssonLThe journey to establish CGRP as a migraine target: a retrospective viewHeadache2015551249125526368117
   PubMed Web of Science ®Google Scholar
• EdvinssonLCGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatmentBr J Clin Pharmacol20158019319925731075
   PubMed Web of Science ®Google Scholar
• HougaardATfelt-HansenPReview of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonistsExpert Opin Drug Metab Toxicol2015111409141826095133
   PubMed Web of Science ®Google Scholar
• BigalMEWalterSBronsonMAlibhoyAEscandonRCardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRPCephalalgia20143496897624662322
   PubMed Web of Science ®Google Scholar
• WalterSAlibhoyAEscandonRBigalMEEvaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptideMAbs2014687187824866108
   PubMed Web of Science ®Google Scholar
• ZellerJPoulsenKTSuttonJECGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the ratBr J Pharmacol20081551093110318776916
   PubMed Web of Science ®Google Scholar
• BigalMEEscandonRBronsonMSafety and tolerability of LBR 101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: results of the Phase 1 programCephalalgia20133448349224366980
   PubMed Web of Science ®Google Scholar
• GiamberardinoMAAffaitatiGCurtoMNegroACostantiniRMartellettiPAnti-CGRP monoclonal antibodies in migraine: current perspectivesIntern Emerg Med20161181045105727339365
   PubMed Web of Science ®Google Scholar
• HouMXingHCaiYThe effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysisJ Headache Pain20171814228389966
   PubMed Web of Science ®Google Scholar
• BarwellJWoottenDSimmsJHayDLPoynerDRRAMPs and CGRP receptorsAdv Exp Med Biol2012744132422434104
   PubMed Web of Science ®Google Scholar
• WalkerCSHayDLCGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?Br J Pharmacol20131707129330723425327
   PubMed Web of Science ®Google Scholar
• ShiLLehtoSGZhuDXDPharmacologic characterization of AMG 334, a potent and selective human monoclonal antibody against the calcitonin gene-related peptide receptorJ Pharmacol Exp Ther201635622323126559125
   PubMed Web of Science ®Google Scholar
• VuTMaPChenJSPharmacokinetic-pharmacodynamic relationship of erenumab (AMG 334) and capsaicin-induced dermal blood flow in healthy and migraine subjectsPharm Res Epub20176710.1007/s11095-017-2183-6
   Web of Science ®Google Scholar
• de HoonJVan HeckenAVandermeulenCPhase 1, randomized, double-blind, placebo-controlled, single-dose and multiple-dose studies of erenumab in healthy subjects and patients with migraineClin Pharmacol Ther Epub201772410.1002/cpt.799
   Web of Science ®Google Scholar
• SunHDodickDWSilbersteinSSafety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trialLancet Neurol201615438239026879279
   PubMed Web of Science ®Google Scholar
• Conference CoverageErenumab May Reduce Headache Days in Episodic Migraine. The monoclonal antibody appears to reduce the impact of migraine on everyday activity and physical functionNeurol Rev2017256140
   Google Scholar
• GiamberardinoMACostantiniRChallenging chronic migraine: targeting the CGRP receptorLancet Neurol201716641041128460891
   PubMed Web of Science ®Google Scholar
• TepperSAshinaMReuterUSafety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trialLancet Neurol201716642543428460892
   PubMed Web of Science ®Google Scholar
• DeenMCorrentiEKammKBlocking CGRP in migraine patients – a review of pros and consJ Headache Pain20171819628948500
   PubMed Web of Science ®Google Scholar
• GiamberardinoMACostantiniRAffaitatiGViscero-visceral hyperalgesia: characterization in different clinical modelsPain2010151230732220638177
   PubMed Web of Science ®Google Scholar
• IuvoneTAffaitatiGDe FilippisDUltramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: role of mast cellsPain20161571809125974242
   PubMed Web of Science ®Google Scholar